Identifiaction of High-Risk Recurrence Patients in Stage I-III NSCLC through Integration of Radiological Tumor Volume and Minimal Residual Disease

Written By Stephanie Avila

Camilla Roberti | Department of Medicine and Surgery, University of Parma, Italy

Stephanie Avila
Previous

Early Tumor Burden Dynamics on CT Scans to Predict Clinical Outcome In Advance NSCLC Patients Undergoing First-line Immune Checkpoint Inhibitors or First-line Chemo-Immunotherapy
Next

Low-Dose Computed Tomography Lung Cancer Screening Participants Show Improved 10-Year Survival Compared with Matched Controls: a Case-Control Study